CLINICAL_TRIALS
trial_result
· 2023-01-13
Clinical Trial Update: Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 3]
Summary
A long-term safety update for anifrolumab in adults with active systemic lupus erythematosus (Phase 3) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Active Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED | Results posted: 2023-01-13